- Home
- RARE vs SID Comparison
RARE vs SID Comparison
Compare RARE & SID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | SID |
|---|---|---|
| Founded | 2010 | 1941 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2014 | 1997 |
Fundamental Metrics
Financial Performance| Metric | RARE | SID |
|---|---|---|
| Price | $23.40 | $1.83 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 19 | 1 |
| Target Price | ★ $73.11 | $1.40 |
| AVG Volume (30 Days) | ★ 4.0M | 3.2M |
| Earning Date | 02-12-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $630,598,000.00 | ★ $8,522,708,358.00 |
| Revenue This Year | $19.68 | $4.93 |
| Revenue Next Year | $19.44 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.63 | 4.02 |
| 52 Week Low | $18.41 | $1.24 |
| 52 Week High | $46.50 | $1.96 |
Technical Indicators
Market Signals| Indicator | RARE | SID |
|---|---|---|
| Relative Strength Index (RSI) | 38.36 | 55.23 |
| Support Level | $22.00 | $1.68 |
| Resistance Level | $24.65 | $1.96 |
| Average True Range (ATR) | 1.28 | 0.08 |
| MACD | 0.19 | -0.00 |
| Stochastic Oscillator | 44.59 | 62.74 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About SID Companhia Siderurgica Nacional S.A.
Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.